Haoxi Health Technology Ltd
HAO1.600USD
+0.030+1.91%
Close 01/13, 16:00（ET）Quotes delayed by 15 min
51.58MMarket Cap
37.91P/E TTM
More Details of Haoxi Health Technology Ltd Company
Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.
Haoxi Health Technology Ltd Info
Ticker SymbolHAO
Company nameHaoxi Health Technology Ltd
IPO dateJan 26, 2024
CEOFan (Zhen)
Number of employees30
Security typeOrdinary Share
Fiscal year-endJan 26
Address801/802, Tower C, Building 103
CityBEIJING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code100101
Phone
Websitehttps://ir.haoximedia.com/
Ticker SymbolHAO
IPO dateJan 26, 2024
CEOFan (Zhen)
Company Executives of Haoxi Health Technology Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Lei Xu
Mr. Lei Xu
Chief Operating Officer, Director
Chief Operating Officer, Director
214.40K
--
Mr. Zhen Fan
Mr. Zhen Fan
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Bo Lyu
Mr. Bo Lyu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jia Liu, CPA
Ms. Jia Liu, CPA
Independent Director
Independent Director
--
--
Mr. Changmao Su
Mr. Changmao Su
Independent Director
Independent Director
--
--
Mr. Jianbing Zhang
Mr. Jianbing Zhang
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Lei Xu
Mr. Lei Xu
Chief Operating Officer, Director
Chief Operating Officer, Director
214.40K
--
Mr. Zhen Fan
Mr. Zhen Fan
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Bo Lyu
Mr. Bo Lyu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jia Liu, CPA
Ms. Jia Liu, CPA
Independent Director
Independent Director
--
--
Mr. Changmao Su
Mr. Changmao Su
Independent Director
Independent Director
--
--
Mr. Jianbing Zhang
Mr. Jianbing Zhang
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2024
FY2023
FY2022
FY2021
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
48.52M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wu (Hongli)
1.56%
Xu (Lei)
1.56%
Citadel Advisors LLC
0.10%
DGS Capital Management, LLC
0.01%
Other
96.77%
Shareholders
Shareholders
Proportion
Wu (Hongli)
1.56%
Xu (Lei)
1.56%
Citadel Advisors LLC
0.10%
DGS Capital Management, LLC
0.01%
Other
96.77%
Shareholder Types
Shareholders
Proportion
Individual Investor
3.12%
Hedge Fund
0.10%
Investment Advisor
0.01%
Other
96.77%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
22
16.02K
0.12%
-132.60K
2025Q3
21
20.78K
0.91%
-127.50K
2025Q2
23
587.55K
27.56%
+15.39K
2025Q1
23
587.55K
27.56%
+15.39K
2024Q4
22
549.38K
25.77%
+28.29K
2024Q3
18
520.14K
29.13%
+53.55K
2024Q2
12
490.59K
82.03%
+25.86K
2024Q1
7
488.73K
83.63%
+488.40K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wu (Hongli)
214.40K
1.56%
--
--
Oct 20, 2025
Xu (Lei)
214.40K
1.56%
--
--
Oct 20, 2025
Citadel Advisors LLC
13.26K
0.1%
-1.45K
-9.86%
Sep 30, 2025
DGS Capital Management, LLC
1.53K
0.01%
+1.53K
--
Dec 31, 2024
TD Securities, Inc.
1.23K
0.01%
+1.23K
--
Sep 30, 2025
Two Sigma Investments, LP
--
0%
-1.95K
-100.00%
Mar 31, 2025
BofA Global Research (US)
4.00
0%
--
--
Sep 30, 2025
Sabby Management, LLC
--
0%
-13.90K
-100.00%
Dec 31, 2024
Anson Funds Management LP.
--
0%
-2.12K
-100.00%
Dec 31, 2024
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Date
Type
Ratio
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
FAQs
Who are the top five shareholders of Haoxi Health Technology Ltd?
The top five shareholders of Haoxi Health Technology Ltd are:
Wu (Hongli) holds 214.40K shares, accounting for 1.56% of the total shares.
Xu (Lei) holds 214.40K shares, accounting for 1.56% of the total shares.
Citadel Advisors LLC holds 13.26K shares, accounting for 0.10% of the total shares.
DGS Capital Management, LLC holds 1.53K shares, accounting for 0.01% of the total shares.
TD Securities, Inc. holds 1.23K shares, accounting for 0.01% of the total shares.
Wu (Hongli) holds 214.40K shares, accounting for 1.56% of the total shares.
Xu (Lei) holds 214.40K shares, accounting for 1.56% of the total shares.
Citadel Advisors LLC holds 13.26K shares, accounting for 0.10% of the total shares.
DGS Capital Management, LLC holds 1.53K shares, accounting for 0.01% of the total shares.
TD Securities, Inc. holds 1.23K shares, accounting for 0.01% of the total shares.
What are the top three shareholder types of Haoxi Health Technology Ltd?
The top three shareholder types of Haoxi Health Technology Ltd are:
Wu (Hongli)
Xu (Lei)
Citadel Advisors LLC
Wu (Hongli)
Xu (Lei)
Citadel Advisors LLC
How many institutions hold shares of Haoxi Health Technology Ltd (HAO)?
As of 2025Q4, 22 institutions hold shares of Haoxi Health Technology Ltd, with a combined market value of approximately 16.02K, accounting for 0.12% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.79%.
What is the biggest source of revenue for Haoxi Health Technology Ltd?
In FY2024, the -- business generated the highest revenue for Haoxi Health Technology Ltd, amounting to -- and accounting for --% of total revenue.
